Assessing Emergency Contraception Availability in LouisianaSince FDA approval of oral emergency contraceptives (EC) in 1998, accessibility of these medications has been a focal point for legislation. In twenty years, options have expanded and all patients can access EC both over the counter (levontogestrel, LTG) and by prescription (ullipristal acetate, UA). This project seeks to define EC accessibility for various geographical areas in Louisiana based on same-day availability of EC at retail pharmacies. Using a secret shopper method whereby participants called local retail pharmacies, researchers gathered information posing as adolescents and physicians. They obtained information on current stock of EC, cost of EC, and additional barriers using a scripted interaction dialogue. Calls were placed to all retail pharmacies in each of four Louisiana metropolitan areas ranging in population from 65,000 to 390,000.